Vaccinex Inc.

11/09/2019 | Press release | Distributed by Public on 11/09/2019 07:08

Poster: Presented at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). Updated interim results from CLASSICAL-Lung, a phase 1b/2 study of pepinemab[...]